Stable Neurodevelopment Seen for Most Children With Familial High Risk for Schizophrenia
FRIDAY, Nov. 18, 2022 (HealthDay News) -- Most children at familial high risk for schizophrenia (FHR-SZ) or bipolar disorder (FHR-BP) have stable neurocognitive development, but some transition to a different, usually more impaired, subgroup, according to a study published online Oct. 6 in Schizophrenia Bulletin.
Christina Bruun Knudsen, from Aarhus University Hospital-Psychiatry in Denmark, and colleagues examined transitions between neurocognitive subgroups among children at FHR-SZ or FHR-BP from age 7 to 11 years in a latent profile analysis that was used to identify subgroups at two assessments based on performance of 320 children across eight neurocognitive functions. Temporal stability in subgroup membership was examined. A reference group of population-based controls was included (199 at age 7 years; 178 at age 11 years).
The researchers identified three subgroups based on neurocognitive performance at both time points: moderately-to-severely impaired, mildly impaired, and above-average subgroups. Overall, 12.8 percent of children transitioned to a different subgroup; 85.2 percent transitioned to a more impaired subgroup. Children transitioning to a more impaired subgroup were differentiated from nontransitioning children by a parental diagnosis of schizophrenia, but not by parental diagnosis of bipolar disorder, global functioning at age 7 years, psychopathology, or sex.
"Most children remained in their subgroup at follow-up, showing stable neurocognitive development from age 7 to 11," the authors write. "However, a substantial minority of children changed subgroup membership, of which almost all transitions were to a more impaired subgroup, indicating developmental lags."
Abstract/Full Text (subscription or payment may be required)
Related Posts
AHA News: New Report Details What to Know About Cardiovascular Disease Symptoms
THURSDAY, Aug. 18, 2022 (American Heart Association News) -- Symptoms of...
La FDA aprueba un medicamento para los gatos con una enfermedad alérgica de la piel
VIERNES, 31 de marzo de 2023 (HealthDay News) -- Los gatos que se lamen y se...
Considerable Medical Costs Associated With Recurrent Vertigo
THURSDAY, Oct. 20, 2022 (HealthDay News) -- The three most common causes of...
Los síntomas de COVID raras veces repuntan tras el tratamiento con Paxlovid, según un estudio
MARTES, 14 de junio de 2022 (HealthDay News) -- A pesar de las preocupaciones de...